for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hapvida Participacoes e Investimentos SA

HAPV3.SA

Latest Trade

11.62BRL

Change

0.42(+3.75%)

Volume

32,681,700

Today's Range

11.18

 - 

11.83

52 Week Range

9.30

 - 

18.46

As of on the Bolsa de Valores do Estado de Sao Paulo ∙ Minimum 15 minute delay

Pricing

Previous Close
11.20
Open
11.36
Volume
32,681,700
3M AVG Volume
403.18
Today's High
11.83
Today's Low
11.18
52 Week High
18.46
52 Week Low
9.30
Shares Out (MIL)
3,891.57
Market Cap (MIL)
43,585.58
Forward P/E
57.35
Dividend (Yield %)
0.33

Next Event

Q4 2021 Hapvida Participacoes e Investimentos SA Earnings Release

Latest Developments

More

BRIEF-Brazil Healthcare Co Hapvida Says It Has Presented Intermedica A Non-Binding Offer For A Merger

Hapvida says Intermedica has presented a non-binding offer for a merger - filing

Brazilian Healthcare Provider Hapvida Agrees To Buy Medical For 294 Million Reais- Filing

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hapvida Participacoes e Investimentos SA

Hapvida Participacoes e Investimentos SA (Hapvida) is a Brazil-based holding healthcare company. The Company and its subsidiaries main activities are the coverage of costs of medical, hospital and dental care of its associates, the provision of medical, hospital and dentistry services and examinations and diagnoses per image. Hapvida has different healthcare facilities such as hospitals, clinics or diagnostic imaging units. The Company operates in the Northeast of Brazil, in more than 10 states such as Alagoas, Amazonas, Bahia, Pernambuco, Rio Grande do Norte, Sergipe, among others.

Industry

Healthcare Facilities

Contact Info

Avenida Heraclito Graca n 406, Centro

60.140-060

Brazil

+55.85.40023633

http://www.hapvida.com.br/

Executive Leadership

Candido Pinheiro Koren de Lima

Chairman of the Board

Jorge Fontoura Pinheiro Koren de Lima

Chief Executive Officer, Director

Mauricio Fernandes Teixeira

Chief Financial Officer, IR Contact Officer

Alain Benvenuti

Chief Operating Officer

Candido Pinheiro Koren De Lima Junior

Chief Commercial and Relationship Officer, Director

Key Stats

2.00 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, BRL)

2018

4.6K

2019

5.6K

2020

8.6K

2021(E)

9.9K
EPS (BRL)

2018

0.248

2019

0.242

2020

0.210

2021(E)

0.186
Price To Earnings (TTM)
69.11
Price To Sales (TTM)
4.78
Price To Book (MRQ)
4.09
Price To Cash Flow (TTM)
29.81
Total Debt To Equity (MRQ)
28.85
LT Debt To Equity (MRQ)
27.58
Return on Investment (TTM)
4.64
Return on Equity (TTM)
3.92

Latest News

Latest News

Factbox-Latest on the worldwide spread of the coronavirus

Three U.S. studies show that a third dose of an mRNA vaccine is key to fighting the Omicron coronavirus variant, providing 90% protection against hospitalization due to COVID-19, the U.S. Centers for Disease Control and Prevention said.

Brazilian competition watchdog approves Hapvida-Notre Dame tie-up

Brazilian competition watchdog Cade has unconditionally approved a tie-up between healthcare providers Hapvida Participacoes e Investimentos SA and Notre Dame Intermedica Participacoes SA, the companies said in separate securities filing on Wednesday.

Hapvida buys Brasilia hospital for $40 million

Brazilian healthcare company Hapvida Participacoes has acquired Viventi hospital in Brasilia for 220 million reais ($40 million), including the operations and real estate, the company said in a securities filing on Wednesday evening.

Latin American M&A booms to 10-year high of $105 billion so far this year

Mergers and acquisitions in Latin America were above $105 billion in the first nine months of the year, the highest volume in a decade, according to Refinitiv data, as large amounts of fresh capital fueled a deal frenzy in the region.

UPDATE 1-Brazil's Hapvida and Sul America in bidding war to buy HB

Brazilian health plan operators Hapvida and Sul America said on Thursday both have increased their binding offers to acquire Grupo HB Saude, according to securities filings.

Brazil M&A activity surges despite raging pandemic, political upheaval

Brazil may be headed for a record year for M&A deals despite the negative economic effects of one of the world's deadliest COVID outbreaks and increasing economic and political turmoil, bankers and lawyers say. M&A volume almost quintupled in the first quarter of 2021 from...

Brazilian hospital operator Care files for IPO

Brazilian hospital chain Care has filed for an initial public offering of roughly 790.5 million reais ($139.42 million), amid a dealmaking boom in Brazil's healthcare sector, according to a securities filing on Wednesday.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 1810 GMT on Monday:

EMERGING MARKETS-Latam FX steady, but Brazil's real, Chilean peso lag on virus woes

* Brazil's real flat on concerns over local strain * Chilean economic activity falls in January * Mexican, Colombian pesos gain on oil prices (Adds details, updates prices) By Susan Mathew and Ambar Warrick March 1 (Reuters) - Most Latin American currencies firmed on Monday...

EMERGING MARKETS-Latam currencies rise as bonds stabilize, commodity prices rise

Latin American currencies firmed on Monday, in line with broader emerging market peers, as yields on U.S. Treasuries calmed after a sharp climb last week, while rising commodity prices also lifted assets in the resource-rich region. Higher oil prices buoyed currencies of...

Brazil's Hapvida, Intermedica detail share swap in $9 bln hospital tie-up

Brazilian insurer and hospital operator Hapvida Participacoes e Investimentos SA and competitor Notre Dame Intermedica Participacoes SA disclosed the share conversion terms of a previously announced tie-up that would create the country's largest hospital chain.

Brazil's overwhelmed healthcare system spawns bonanza for dealmakers

Brazil's public health system has been pushed to the breaking point by one of the world's deadliest coronavirus outbreaks, but its private healthcare sector is experiencing an unlikely dealmaking boom.

Experian says investigating if involved in Brazil data breach

Credit data firm Experian said on Monday it was continuing to investigate whether the personal data of millions of people in Brazil that was found to be illegally offered for sale online could be connected with its Brazilian business Serasa.

Brazil's Hapvida still interested in acquisitions after deal with Intermedica

Brazilian healthcare company Hapvida SA would remain interested in acquiring "high quality assets" after a potential tie-up with its rival Notre Dame Intermedica, its CEO Jorge Pinheiro told analysts on Monday.

UPDATE 4-Hapvida bids $9 bln for Intermedica, to create Brazil's top hospital chain

Insurer and hospital operator Hapvida on Friday offered to buy rival Notre Dame Intermedica for 49 billion reais ($9.04 billion) in an all-share deal that would create the country's largest hospital chain.

Brazil's Hapvida discloses cyber breach, potential client data leak

Brazilian health insurer Hapvida said in a securities filing on Monday it has suffered a cyber attack potentially involving access to the personal information of its customers.

Brazil's Hapvida says customer defaults not significant so far, despite coronavirus

Brazilian healthcare operator Hapvida SA sees customer default and insurance claims under control in 2020, despite the growing number of COVID-19 cases in Brazil, its Chief Executive Jorge Fontoura Pinheiro de Lima told analysts on Thursday.

ATUALIZA 1-Hapvida amplia receitas, mas lucro cai no 1º tri, com impacto de aquisições

A administradora de serviços de saúde Hapvida teve forte aumento das receitas no primeiro trimestre, com impulso de um forte ciclo de aquisições recentes, mas seu lucro caiu no comparativo anual, com impacto de despesas financeiras e provisões para ressarcimento ao SUS.

Hapvida tem lucro líquido de R$164,6 mi no 1º tri

* TEM EBITDA DE R$467,8 MILHÕES NO 1º TRI Fonte do documento no Eikon: Para mais notícias sobre a empresa, clique em

Hapvida adia divulgação de resultado para 20 de maio

* ADIA DIVULGAÇÃO DE RESULTADO DO 1º TRIMESTRE DE 13 PARA 20 DE MAIO-COMUNICADO Fonte do documento no Eikon: Para mais notícias sobre a empresa, clique em (Reportagem de Paula Arend Laier)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up